Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials

Oct. 18, 1996

Broader role of VEGF in tumor growth proposed

Oct. 18, 1996

Chemokine/cytokine combination effective for tumor therapy

Oct. 18, 1996

Japanese researchers report new antitumor antibiotics

Oct. 18, 1996

Kyowa Hakko reports antiestrogenic agents

Oct. 18, 1996

Gene therapy reduces the side effects of chemotherapy

Oct. 11, 1996

New strategy for reducing doxorubicin toxicity

Oct. 11, 1996

First photodynamic therapy approved in the U.S.

Oct. 11, 1996

Clinical trial program for anticancer HER-2/neu inhibitor

Oct. 11, 1996

SuperGen acquires rights to Warner-Lambert anticancer drug

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...